Recent studies showed impaired PHA response of patients with tuberculosis in IFN-γ release assays (IGRA) and demonstrated the applicability of this marker for diagnosis of tuberculosis disease and for monitoring treatment efficacy [8–10]. The gene discussed is IFNG; the disease is tuberculosis.